Take control of your 340B program with in-house office dispensing—reduce audit risk, eliminate contract pharmacy complexity, and retain more savings with RxFusion.
The Shift Away from Contract Pharmacy
For years, contract pharmacy has been the default model for 340B programs. But today, it’s becoming one of the biggest sources of risk, complexity, and lost revenue for covered entities.
With increasing manufacturer restrictions and audit scrutiny, many organizations are asking:
Is contract pharmacy still worth it?
For a growing number of 340B participants, the answer is no.
The Hidden Costs of Contract Pharmacy
On the surface, contract pharmacy appears convenient. In reality, it introduces layers of inefficiency that impact both compliance and financial performance.
Where Contract Pharmacy Falls Short:
- Fragmented data across multiple vendors and systems
- Limited visibility into claims eligibility and validation
- Increased manufacturer audit exposure
- High admin fees and revenue sharing
- Delays in reconciliation and reporting
The result? Less control, more risk, and reduced 340B savings.
In-House Office Dispensing Puts You Back in Control
In-house office dispensing flips the model.
Instead of relying on third parties, your organization dispenses medications directly to patients at the point of care—with full ownership of the process.
Why Covered Entities Are Making the Switch:
- Centralized, real-time data
- Direct oversight of compliance
- Faster access to medications for patients
- Improved operational efficiency
- Greater financial transparency
This isn’t just an operational improvement—it’s a strategic advantage.
Audit Readiness Starts with Data Control
The biggest difference between contract pharmacy and in-house dispensing?
Control of your data.
With contract pharmacy, your audit trail is only as strong as your vendors. With in-house office dispensing powered by RxFusion, everything is unified.
With RxFusion, You Get:
- A single-source data system
- Audit-ready reporting on demand
- Automated compliance tracking
- Clear documentation for every transaction
- Reduced risk of duplicate or ineligible claims
No scrambling. No guesswork. Just audit confidence.
Side-by-Side Comparison
Contract Pharmacy vs In-House Office Dispensing
| Capability | Contract Pharmacy | In-House with RxFusion |
|---|---|---|
| Data Visibility | Limited, fragmented | Full, real-time |
| Audit Readiness | Reactive | Proactive |
| Fees | High, layered | Lower, simplified |
| Compliance Risk | Elevated | Controlled |
| Savings Retention | Reduced | Maximized |
| Operational Control | Third-party dependent | Fully in-house |
Maximize Savings by Eliminating Middlemen
Contract pharmacy models often take a significant share of your 340B margin through:
- Admin fees
- Dispensing fees
- Revenue splits
RxFusion’s in-house model eliminates unnecessary intermediaries—allowing you to:
- Retain more 340B savings
- Improve program ROI
- Reinvest in patient care
Built for Modern 340B Programs
RxFusion supports a wide range of covered entities, including:
- FQHCs
- Community health centers
- Hospitals and health systems
- Ryan White clinics
If your organization is navigating increased audit pressure and shrinking margins, in-house office dispensing is the path forward.
Turn Compliance Into a Competitive Advantage
The future of 340B isn’t just about participation—it’s about optimization.
Organizations that shift to in-house dispensing are gaining:
- Stronger compliance posture
- Better financial performance
- Improved patient outcomes
- Long-term program sustainability
Take Back Control of Your 340B Program
Stop losing margin to contract pharmacies.
Start building a compliant, audit-ready, in-house model.
👉 Request a Consultation
👉 See Your Potential Savings
Visit: www.rxfusion.com or Email: hello@rxfusion.com